Leonard JP - Search Results

1

Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.

Cols M, Barra CM, He B, Puga I, Xu W, Chiu A, Tam W, Knowles DM, Dillon SR, Leonard JP, Furman RR, Chen K, Cerutti A. Cols M, et al. Among authors: leonard jp. J Immunol. 2012 Jun 15;188(12):6071-83. doi: 10.4049/jimmunol.1102066. Epub 2012 May 16. J Immunol. 2012. PMID: 22593611 Free PMC article.

2

Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma.

Leonard JP, Coleman M, Ketas JC, Chadburn A, Ely S, Furman RR, Wegener WA, Hansen HJ, Ziccardi H, Eschenberg M, Gayko U, Cesano A, Goldenberg DM. Leonard JP, et al. J Clin Oncol. 2003 Aug 15;21(16):3051-9. doi: 10.1200/JCO.2003.01.082. Epub 2003 Jul 1. J Clin Oncol. 2003. PMID: 12837807 Clinical Trial.

3

Epratuzumab in non-Hodgkin's lymphomas.

Furman RR, Coleman M, Leonard JP. Furman RR, et al. Among authors: leonard jp. Curr Treat Options Oncol. 2004 Aug;5(4):283-8. doi: 10.1007/s11864-004-0019-1. Curr Treat Options Oncol. 2004. PMID: 15233905 Review.

4

Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.

Leonard JP, Coleman M, Ketas J, Ashe M, Fiore JM, Furman RR, Niesvizky R, Shore T, Chadburn A, Horne H, Kovacs J, Ding CL, Wegener WA, Horak ID, Goldenberg DM. Leonard JP, et al. J Clin Oncol. 2005 Aug 1;23(22):5044-51. doi: 10.1200/JCO.2005.13.821. Epub 2005 Jun 13. J Clin Oncol. 2005. PMID: 15955901 Clinical Trial.

5

New developments in immunotherapy for non-Hodgkin's lymphoma.

Leonard JP, Furman RR, Ruan J, Coleman M. Leonard JP, et al. Curr Oncol Rep. 2005 Sep;7(5):364-71. doi: 10.1007/s11912-005-0063-4. Curr Oncol Rep. 2005. PMID: 16091197 Review.

6

Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.

Leonard JP, Coleman M, Kostakoglu L, Chadburn A, Cesarman E, Furman RR, Schuster MW, Niesvizky R, Muss D, Fiore J, Kroll S, Tidmarsh G, Vallabhajosula S, Goldsmith SJ. Leonard JP, et al. J Clin Oncol. 2005 Aug 20;23(24):5696-704. doi: 10.1200/JCO.2005.14.803. J Clin Oncol. 2005. PMID: 16110029 Clinical Trial.

7

Proteasome inhibition with bortezomib: a new therapeutic strategy for non-Hodgkin's lymphoma.

Leonard JP, Furman RR, Coleman M. Leonard JP, et al. Int J Cancer. 2006 Sep 1;119(5):971-9. doi: 10.1002/ijc.21805. Int J Cancer. 2006. PMID: 16557600 Review.

8

Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.

Furman RR, Coleman M, Muss D, Leonard JP. Furman RR, et al. Among authors: leonard jp. Cancer Treat Res. 2006;131:221-50. doi: 10.1007/978-0-387-29346-2_7. Cancer Treat Res. 2006. PMID: 16704171 Review. No abstract available.

9

FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.

Kostakoglu L, Goldsmith SJ, Leonard JP, Christos P, Furman RR, Atasever T, Chandramouly A, Verma S, Kothari P, Coleman M. Kostakoglu L, et al. Among authors: leonard jp. Cancer. 2006 Dec 1;107(11):2678-87. doi: 10.1002/cncr.22276. Cancer. 2006. PMID: 17063502 Free article.

10

Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement.

Mones JV, Coleman M, Kostakoglu L, Furman RR, Chadburn A, Shore TB, Muss D, Stewart P, Kroll S, Vallabhajosula S, Goldsmith SJ, Leonard JP. Mones JV, et al. Among authors: leonard jp. Leuk Lymphoma. 2007 Feb;48(2):342-8. doi: 10.1080/10428190601059720. Leuk Lymphoma. 2007. PMID: 17325895 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters